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Leukemia is a malignant neoplasm of the hematopoietic stem cells characterized by diffuse replacement of bone marrow by neoplastic cells [1]. The most prevalent 
childhood cancer is leukemia, and acute lymphoblastic leukemia 
(ALL) constitutes 75% of all cases. Leukemia usually presents 
with nonspecific symptoms such as anorexia, fatigue, and 
irritability [2]. As the disease progresses, pallor, bleeding 
tendency, hepatosplenomegaly, and lymphadenopathy may 
appear. Uncommon initial manifestations are joint pain, proptosis, 
abdominal pain, melena, diarrhea, and dysphagia among others. In 
various studies, a correlation between the prognosis and various 
clinical and laboratory finding at the time of diagnosis (sex, white 
blood cell counts, organ infiltration: Liver, spleen, lymph node) 
has been quoted [3,4]. The present study aims to find the most 
common clinical and hematological findings of pediatric patients 
with acute leukemia at a tertiary care center of central India.
MATERIALS AND METHODS
This retrospective study was conducted in the Department of 
Pediatrics and Department of Oncology at Chirayu Medical 
College and Hospital, Bhopal, from June 2014 to June 2015. This 
study included children of ages 6 months-15 years admitted with 
a new diagnosis of acute leukemia. Following definition was used 
for confirmatory diagnosis of leukemia: Acute leukemia >20% of 
the blast in bone marrow, or hyperleukocytosis - leukocyte count 
>1,00,000/mm3. The French–American–British classification 
was used for morphological classification of ALL [5,6].
A predesigned pro forma was made in which patient 
characteristics were entered. Medical records were studied 
and data were collected which included age, sex, income, and 
education of the parents. In addition, clinical features such as fever, 
hepatomegaly, splenomegaly, lymphadenopathy, gum bleeding, 
and other rare presentations such as joint pain, gastrointestinal 
bleeding, abdominal pain, proptosis, and dysphagia were noted. 
Chest X-ray in all cases, along with radiograph of relevant joints 
involved in symptomatic cases, was performed.
The diagnosis of leukemia was based on findings of complete 
blood count, bone marrow examinations which included cytological 
stains such as periodic acid–Schiff and Sudan black. Written 
informed consent was obtained for any invasive procedure(s). 
Fine-needle aspiration cytology was performed wherever it was 
clinically indicated. Bone marrow examination was considered 
the gold standard for diagnosis. Immunophenotyping was done 
only in difficult cases due to economic constraints, and hence it 
is not included in the analysis. Secondary and relapsed cases of 
acute leukemia were excluded.
Statistical Analysis
The data were entered in the Microsoft Office Excel 2007, 10% 
of the data were reentered to check for the data entry errors. 
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The data were analyzed using Epi-info software (available free 
online). The quantitative data were summarized as percentage 
while quantitative as mean and standard deviation.
RESULTS
A total of 35 children between 6 months and 15 years of age 
were enrolled in the study. Five children were excluded as they 
did not fit the inclusion criteria. Of 30 children, 22 (73.3%) 
children had ALL, 6 (20%) had acute myeloid leukemia (AML), 
and 2 (6.6%) had biphenotypic leukemia. Among children with 
ALL, B-cell subtype was the majority, and found in 14 (63%) 
children, followed by T-cell subtype noted in 6 (27%) children. 
Burkitt lymphoma was found in 2 (9%) children. In our study, the 
mean age for ALL was 6.1±1.7 years (range 10 months-10 years). 
The mean age for AML was 10.5 years (range 4-15 years). The 
male:female ratio in our study was 2.2:1.
Among the presenting symptoms, fever and fatigue were most 
commonly documented, followed by bleeding and abdominal 
distension. Hepatosplenomegaly and lymphadenopathy were the 
most frequent findings on clinical examination. Skin bleeding 
was more often documented in B-cell leukemia. In children with 
AML, proptosis was present in 4%. History suggestive of central 
nervous system involvement was present in 5 children. Lumbar 
puncture was performed on these children, of which one patient 
was diagnosed with central nervous system involvement of ALL. 
Clinical features of the study population are shown in Table 1.
Mean hemoglobin was 6.19±2.1 g/dL at presentation. Mean 
leukocyte count was 50,000±5400/mm3 and 35,000±6700/mm3 
in ALL and AML, respectively, while mean platelet count was 
42,000±7650/mm3 and 30,000±8790/mm3 in ALL and AML, 
respectively (Table 2). The bone marrow was hypercellular 
comprising sheets of blast cells in most of the cases. Average blast 
cells were 85±12.3% and 40±13.7% in ALL and AML, respectively. 
The majority of the patients with B-cell ALL (90%) were CALLA-
positive. Among ALL, L1 (54%) was the most commonly noted 
subtype, followed by L2 (36%) and then L3 (9%). Among AML, 
M2 and M3 were 33 % each, M1 and M4 were 16% each (Table 3).
DISCUSSION
In the present study, incidence of ALL and AML was found to be 
73.3% and 20%. This is comparable to the study conducted by 
Young et al. [7]. In our study, mean age for occurrence of ALL 
is 6.1±1.7 years (10 months-10 years) and in AML is 10.5 years 
(4-15 years). Of 30 patients, 21 were male and 9 were female. The 
male:female ratio was 2.2:1, showing male preponderance. This 
finding is similar to the study done by Jussawalla et al. [8].
Fever (73%) was the most common symptom in our study. 
Similar findings are also documented in a study by Karimi 
et al. [9]. Severe anemia and thrombocytopenia were common 
presenting features in our study. These observations are also 
similar to the findings documented in studies done by Rani et al., 
and Dores et al. [10,11]. Leukocytosis was observed in 48% cases 
and hyperleukocytosis was observed in 26.6% of cases of acute 
leukemia.
While considering AML, leukocytosis was seen in 66.6% 
and hyperleukocytosis was seen in 16.6%. The prevalence of 
hepatomegaly (63%), splenomegaly (60%), and lymphadenopathy 
(50%) was similar to that reported in other studies [9,10]. Central 
nervous system involvement was seen in 3.3% of the cases. The 
distribution of subtypes of ALL (ALL1 [54%], ALL2 [36%], 
and ALL3 [10%]) is similar to the study done by Poplack [12]. 
Among AML, M1 and M4 were each 16% and M2 and M3 were 
33% each. Three patients of acute leukemia presented with joint 
pain and 1 patient (ALL) had bone pain.
The etiology of bone pain in acute leukemia could be due 
to direct leukemic infiltration of periosteum or bone infarction. 
Four cases of acute leukemia presented with abdominal pain. 
Abdominal pain and gastrointestinal bleeding have been reported 
as initial manifestations of acute leukemia previously by Robazzi 
et al. [13]. Among the non-specific symptoms, our study found 
a lower incidence of fatigue (66.6%) in contrast to the high 
rate of 92% documented in literature among all the patients 
of leukemia [14]. This lower incidence may be due to lack of 
appreciation in children. Anorexia was also observed in 40% 
of children which is also a non-specific symptom. One child 
presented with testicular involvement due to direct infiltration of 
organ. The limitation of this study was small number of cases.
CONCLUSION
From our study, we concluded that ALL is most common 
hematological malignancy. Fever was the most common presenting 
symptom followed by fatigue and anorexia. Hepatosplenomegaly 
was most common finding on clinical examination. Among ALL, 
Table 1: Clinical features of study population
Clinical features n (%)
Symptoms
Fever 22 (73)
Fatigue 20 (66.6)
Pallor 19 (63.6)
Bleeding 18 (60)
Anorexia 16 (53.3)
Weight loss 13 (43.3)
Skin rash 12 (40)
Abdominal 
distension
9 (30)
Abdominal pain 4 (13.3)
Joint pain 3 (10)
Signs
Hepatomegaly 19 (63)
Splenomegaly 18 (60)
Lymphadenopathy 15 (50)
Proptosis 4 (13)
Ascites 3 (10)
Meningeal sign 1 (3.3)
Total 30 (100)
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L1 was most common type. Among AML, M2 and M3 were more 
common. Further larger studies are required to corroborate our 
findings.
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Table 2: Laboratory investigations
Parameters B-cell (14) T-cell (6) Burkitt (2) AML (6) Biphenotypic (2)
Leukocyte counts (mm3)
<4000 2 1
4000-10,000 3 1 1
10,000-50,000 3 1 2 2
50,000-100,000 2 2 2
>100,000 4 2 1 1
Platelet counts (mm3)
<10,000 3 2
10,000-50,000 3 2 2 3 2
50,000-100,000 3 2 1
100,000-200,000 4 2
>200,000 1
AML: Acute myeloid leukemia
Table 3: Bone marrow diagnosis
Diagnosis n (%)
ALL 22 (73)
L1 12 (54)
L2 8 (36)
L3 2 (9)
AML 6 (20)
M1 1 (16)
M2 2 (33)
M3 2 (33)
M4 1 (16)
Biphenotypic 2 (7)
Total 30 (100)
AML: Acute myeloid leukemia
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